Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 01, 2022 08:00 ET | Source: CARRICK THERAPEUTICS LIMITED

Carrick Therapeutics Announces $35 Million Investment from Pfizer

Funding supports advancement of samuraciclib, an oral CDK7 inhibitor, in combination with endocrine therapy for HR+, HER2- advanced breast cancer Adam Schayowitz, Ph.D., Vice President and...